# Context Therapeutics Inc.: filings

CNTX · Nasdaq · CIK 1842952 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cntx.md) · [Financials](/companies/cntx/financials.md) · [Filings](/companies/cntx/filings.md) · [Insiders](/companies/cntx/insiders.md)

## Reports and events: 88 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 69, 8-K 53, SCHEDULE 13G/A 20, 10-Q 15, 3 15, CORRESP 15, 424B3 11, SC 13G 11, UPLOAD 9, SC 13G/A 8, EFFECT 7, FWP 7, S-1/A 7, DEF 14A 6, DEFA14A 6, S-8 6, 10-K 5, PRE 14A 4, ARS 3, S-3 3, SCHEDULE 13G 3, 3/A 2, 424B4 2, 424B5 2, 4/A 2, DRSLTR 2, POS AM 2, S-1 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:16 ET | [8-K](/filings/0001628280-26-053378.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-053378 |
| 2026-08-05 | 16:09 ET | [10-Q](/filings/0001628280-26-053347.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053347 |
| 2026-07-31 | 16:08 ET | [8-K](/filings/0001628280-26-051399.md) | 3.01 Delisting notice | 0001628280-26-051399 |
| 2026-06-26 | 16:07 ET | [8-K](/filings/0001628280-26-045744.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-045744 |
| 2026-06-15 | 09:18 ET | [8-K](/filings/0001628280-26-043042.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043042 |
| 2026-05-18 | 06:47 ET | [8-K](/filings/0001628280-26-035793.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-035793 |
| 2026-05-06 | 16:10 ET | [10-Q](/filings/0001628280-26-031267.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031267 |
| 2026-05-01 | 16:07 ET | [8-K](/filings/0001628280-26-029323.md) | 8.01 Other events | 0001628280-26-029323 |
| 2026-04-28 | 16:12 ET | [DEF 14A](/filings/0001628280-26-027928.md) | Proxy statement, period 2026-04-28 | 0001628280-26-027928 |
| 2026-04-02 | 07:41 ET | [8-K](/filings/0001628280-26-022931.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-022931 |
| 2026-03-23 | 16:22 ET | [8-K](/filings/0001628280-26-020517.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-020517 |
| 2026-03-23 | 16:09 ET | [10-K](/filings/0001628280-26-020498.md) | Annual report, period 2025-12-31 | 0001628280-26-020498 |
| 2026-03-13 | 16:09 ET | [8-K](/filings/0001628280-26-017691.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-017691 |
| 2026-02-27 | 16:11 ET | [8-K](/filings/0001628280-26-012813.md) | 8.01 Other events | 0001628280-26-012813 |
| 2026-01-08 | 07:43 ET | [8-K](/filings/0001628280-26-001275.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001275 |
| 2025-11-05 | 16:21 ET | [8-K](/filings/0001628280-25-049604.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-049604 |
| 2025-11-05 | 16:08 ET | [10-Q](/filings/0001628280-25-049533.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049533 |
| 2025-10-24 | 16:02 ET | [8-K](/filings/0001628280-25-046258.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-046258 |
| 2025-10-20 | 16:04 ET | [8-K](/filings/0001628280-25-045513.md) | 8.01 Other events | 0001628280-25-045513 |
| 2025-09-02 | 07:32 ET | [8-K](/filings/0001842952-25-000085.md) | 3.01 Delisting notice | 0001842952-25-000085 |
| 2025-08-06 | 16:07 ET | [10-Q](/filings/0001842952-25-000081.md) | Quarterly report, period 2025-06-30 | 0001842952-25-000081 |
| 2025-06-12 | 17:14 ET | [8-K](/filings/0001842952-25-000072.md) | 5.07 Shareholder vote results | 0001842952-25-000072 |
| 2025-06-02 | 07:34 ET | [8-K](/filings/0001842952-25-000051.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000051 |
| 2025-05-07 | 16:05 ET | [10-Q](/filings/0001842952-25-000048.md) | Quarterly report, period 2025-03-31 | 0001842952-25-000048 |
| 2025-04-15 | 16:05 ET | [DEF 14A](/filings/0001842952-25-000042.md) | Proxy statement, period 2025-06-12 | 0001842952-25-000042 |
| 2025-04-09 | 07:33 ET | [8-K](/filings/0001842952-25-000037.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000037 |
| 2025-03-20 | 16:15 ET | [10-K](/filings/0001842952-25-000028.md) | Annual report, period 2024-12-31 | 0001842952-25-000028 |
| 2025-02-28 | 16:06 ET | [8-K](/filings/0001842952-25-000024.md) | 3.01 Delisting notice | 0001842952-25-000024 |
| 2025-01-14 | 17:03 ET | [8-K](/filings/0001842952-25-000006.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-25-000006 |
| 2025-01-13 | 07:37 ET | [8-K](/filings/0001842952-25-000003.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-25-000003 |
| 2024-12-23 | 09:26 ET | [8-K](/filings/0001842952-24-000087.md) | 8.01 Other events | 0001842952-24-000087 |
| 2024-12-02 | 16:21 ET | [8-K](/filings/0001628280-24-049570.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-049570 |
| 2024-11-06 | 16:02 ET | [10-Q](/filings/0001842952-24-000085.md) | Quarterly report, period 2024-09-30 | 0001842952-24-000085 |
| 2024-09-23 | 07:33 ET | [8-K](/filings/0001842952-24-000083.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000083 |
| 2024-09-17 | 16:22 ET | [8-K](/filings/0001842952-24-000081.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001842952-24-000081 |
| 2024-09-04 | 07:34 ET | [8-K](/filings/0001842952-24-000070.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000070 |
| 2024-08-07 | 16:07 ET | [10-Q](/filings/0001842952-24-000065.md) | Quarterly report, period 2024-06-30 | 0001842952-24-000065 |
| 2024-07-24 | 16:55 ET | [DEF 14A](/filings/0001842952-24-000055.md) | Proxy statement, period 2024-09-17 | 0001842952-24-000055 |
| 2024-07-10 | 07:33 ET | [8-K](/filings/0001842952-24-000050.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000050 |
| 2024-06-14 | 07:34 ET | [8-K](/filings/0001842952-24-000041.md) | 5.07 Shareholder vote results | 0001842952-24-000041 |
| 2024-05-08 | 16:03 ET | [10-Q](/filings/0001842952-24-000035.md) | Quarterly report, period 2024-03-31 | 0001842952-24-000035 |
| 2024-05-02 | 07:37 ET | [8-K](/filings/0001842952-24-000033.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000033 |
| 2024-04-26 | 16:10 ET | [DEF 14A](/filings/0001842952-24-000027.md) | Proxy statement, period 2024-06-13 | 0001842952-24-000027 |
| 2024-04-01 | 07:32 ET | [8-K](/filings/0001842952-24-000022.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-24-000022 |
| 2024-03-21 | 07:36 ET | [10-K](/filings/0001842952-24-000011.md) | Annual report, period 2023-12-31 | 0001842952-24-000011 |
| 2024-03-21 | 07:31 ET | [8-K](/filings/0001842952-24-000010.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001842952-24-000010 |
| 2024-03-06 | 07:30 ET | [8-K](/filings/0001842952-24-000005.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001842952-24-000005 |
| 2023-11-09 | 16:04 ET | [10-Q](/filings/0001842952-23-000085.md) | Quarterly report, period 2023-09-30 | 0001842952-23-000085 |
| 2023-10-31 | 09:04 ET | [8-K](/filings/0001842952-23-000082.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001842952-23-000082 |
| 2023-08-09 | 16:04 ET | [10-Q](/filings/0001842952-23-000078.md) | Quarterly report, period 2023-06-30 | 0001842952-23-000078 |

Page 1 of 2. [Older](/companies/cntx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.